Ivermectin Use in Humans: Evidence-Based Assessment
COVID-19 Evidence and Recommendations
- The Infectious Diseases Society of America (IDSA) explicitly recommends against ivermectin use for COVID-19, with a conditional recommendation against use for hospitalized patients (very low certainty of evidence) and a strong recommendation against use for ambulatory persons (moderate certainty of evidence) 1, 2
- The IDSA notes that in vitro activity against SARS-CoV-2 requires concentrations considerably higher than achievable in human plasma and lung tissue, and clinical trials showed no consistent benefit for COVID-19 treatment 1, 2
Safety Considerations
- Higher doses of ivermectin potentially needed for non-approved uses may cause significant adverse effects, according to the Infectious Diseases Society of America 1